Patent Ductus Arteriosus: Paracetamol Treatment in Premature Infants

We are studying whether early treatment with Paracetamol helps extremely low birth weight infants with Patent Ductus Arteriosus avoid serious complications. This trial compares the effects of Paracetamol to a placebo.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Paracetamol
Paracetamol is a substance that relieves pain and reduces fever.
Sodium Chloride
Sodium chloride is a substance used to replace salts and fluids in the body and to clean or irrigate wounds and nasal passages.

What experimental substances are being tested?

Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.

Sodium Chloride

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Fakultni Nemocnice Ostrava
Department of Paediatrics and Newborn Medicine
Hlučín, Czechia
The Institute For The Care Of Mother And Child
Department of Children and Adolescents 3FM CU and UHKV
Prague, Czechia
Fakultni Nemocnice V Motole
Department of Obstetrics and Gynaecology
Stodůlky, Czechia

Sponsor: University College Dublin
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.